(HealthDay)—Social media can be a powerful motivating tool. But if your goal is to get to the gym more often, competition beats friendly support on social networking sites, a new study contends.
Nov 9, 2016
0
2
Heart abnormalities linked to immersion pulmonary edema were present in a greater-than-expected proportion of triathletes who died during the competition's swim portion, according to a study led by researchers at Duke Health.
Sep 1, 2016
0
0
The Food and Drug Administration released its proposal Thursday for naming lower-cost biotech drugs, a critical step in creating a market for the new class of medicines.
Aug 27, 2015
0
5
The soft signs of compulsive gambling—high energy levels, unreasonable expectations, extreme competitiveness, distorted optimism and above-average IQs—are often the very traits that characterize competing athletes. However, ...
May 11, 2015
0
14
Federal health officials have approved the first lower-cost copy of a biotech drug to reach the U.S. market, a long-awaited milestone that could generate billions in savings for insurers, doctors and patients.
Mar 6, 2015
0
9
(AP)—The Supreme Court ruled Wednesday that a state regulatory board made up mostly of dentists violated federal law against unfair competition when it tried to prevent lower-cost competitors in other fields from offering ...
Feb 25, 2015
1
4
According to the Centers for Disease Control and Prevention, two million people become infected with antibiotic resistant bacteria each year, leading to at least 23,000 deaths. And these infections cost a lot – US$20billion ...
Feb 9, 2015
0
8
Medical practices in less competitive health-care markets charge more for services, according to a study conducted by researchers at the Stanford University School of Medicine and the National Bureau of Economic Research.
Oct 21, 2014
0
0
The maker of the world's top-selling erectile dysfunction drug on Tuesday will begin airing the first Viagra TV commercial in America that targets the less-obvious sufferers of the sexual condition: women.
Sep 30, 2014
0
0
Warfarin, the longtime standard treatment for atrial fibrillation, is facing competition from new options in the anticoagulant drug marketplace including dabigatran, rivaroxaban, and apixaban. A new study documents the rapid ...
Aug 19, 2014
0
0
